Tsumura & Company Overview

  • Founded
  • 1893
Founded
  • Status
  • Public
  • Employees
  • 5,074
Employees
  • Stock Symbol
  • 4540
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $29.94
  • (As of Friday Closing)

Tsumura & Company General Information

Description

Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 2-7-17-1
  • Akasaka, Minato-ku
  • Tokyo, 107-8521
  • Japan
+81 00-0000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tsumura & Company Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$29.94 $30.43 $20.61 - $32.23 $2.29B 76.5M 177K $1.68

Tsumura & Company Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 2,106,744 1,881,454 2,169,408 2,345,696
Revenue 1,149,340 1,133,112 1,090,490 1,063,408
EBITDA 239,452 231,664 233,727 238,740
Net Income 128,574 126,552 131,619 130,840
Total Assets 2,905,811 2,878,072 2,591,300 2,751,286
Total Debt 615,478 603,925 448,144 608,733
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tsumura & Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tsumura & Company‘s full profile, request access.

Request a free trial

Tsumura & Company Executive Team (1)

Name Title Board Seat Contact Info
Terukazu Kato President & Representative Director
To view Tsumura & Company’s complete executive team members history, request access »

Tsumura & Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tsumura & Company Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tsumura & Company‘s full profile, request access.

Request a free trial

Tsumura & Company Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00 0 0000000 30-Nov-2017 00000 0000000 Drug Discovery 00000000 0000
To view Tsumura & Company’s complete investments history, request access »